Inhibition of Hsp90 acts synergistically with topoisomerase II poisons to increase the apoptotic killing of cells due to an increase in topoisomerase II mediated DNA damage
Authors:
- Anne V. McNamaraAMAnne V. McNamara
- Stephen A. RackstrawSRStephen A. Rackstraw
- Mike R. WhiteMWMike R. White
- Alastair J. M. WatsonAWAlastair J. M. Watson
- John R. JenkinsJJJohn R. Jenkins
Open Access
- 13 February 2006
- journal article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 34 (4) , 1148-1157
Abstract
Topoisomerase II plays a crucial role during chromosome condensation and segregation in mitosis and meiosis and is a highly attractive target for chemotherapeutic agents. We have identified previously topoisomerase II and heat shock protein 90 (Hsp90) as part of a complex. In this paper we demonstrate that drug combinations targeting these two enzymes cause a synergistic increase in apoptosis. The objective of our study was to identify the mode of cell killing and the mechanism behind the increase in topoisomerase II mediated DNA damage. Importantly we demonstrate that Hsp90 inhibition results in an increased topoiosmerase II activity but not degradation of topoisomerase II and it is this, in the presence of a topoisomerase II poison that causes the increase in cell death. Our results suggest a novel mechanism of action where the inhibition of Hsp90 disrupts the Hsp90–topoisomerase II interaction leading to an increase in and activation of unbound topoisomerase II, which, in the presence of a topoisomerase II poison leads to the formation of an increased number of cleavable complexes ultimately resulting in rise in DNA damage and a subsequent increase cell death.Keywords
This publication has 25 references indexed in Scilit:
- The Role of Checkpoint Kinase 1 in Sensitivity to Topoisomerase I PoisonsJournal of Biological Chemistry, 2005
- The relative contribution of CHK1 and CHK2 to Adriamycin-induced checkpointExperimental Cell Research, 2005
- Cdk Inhibition in Human Cells Compromises Chk1 Function and Activates a DNA Damage ResponseCancer Research, 2005
- Hsp90: an emerging target for breast cancer therapyAnti-Cancer Drugs, 2004
- Therapeutic and diagnostic implications of Hsp90 activationTrends in Molecular Medicine, 2004
- Hsp90 Inhibition Depletes Chk1 and Sensitizes Tumor Cells to Replication StressJournal of Biological Chemistry, 2003
- Isolation of cDNA clones encoding the β isozyme of human DNA topoisomerase II and localisation of the gene to chromosome 3p24Nucleic Acids Research, 1992
- Unusual expression and localization of heat‐shock proteins in human tumor cellsInternational Journal of Cancer, 1992
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990
- Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22.Proceedings of the National Academy of Sciences, 1988